AU2001250212A1 - Rhamm peptide conjugates - Google Patents
Rhamm peptide conjugatesInfo
- Publication number
- AU2001250212A1 AU2001250212A1 AU2001250212A AU5021201A AU2001250212A1 AU 2001250212 A1 AU2001250212 A1 AU 2001250212A1 AU 2001250212 A AU2001250212 A AU 2001250212A AU 5021201 A AU5021201 A AU 5021201A AU 2001250212 A1 AU2001250212 A1 AU 2001250212A1
- Authority
- AU
- Australia
- Prior art keywords
- peptide conjugates
- rhamm peptide
- rhamm
- conjugates
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101150029182 Hmmr gene Proteins 0.000 title 1
- 239000000863 peptide conjugate Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19861300P | 2000-04-20 | 2000-04-20 | |
| US60/198,613 | 2000-04-20 | ||
| PCT/CA2001/000533 WO2001080899A2 (en) | 2000-04-20 | 2001-04-20 | Rhamm peptide conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001250212A1 true AU2001250212A1 (en) | 2001-11-07 |
Family
ID=22734084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001250212A Abandoned AU2001250212A1 (en) | 2000-04-20 | 2001-04-20 | Rhamm peptide conjugates |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040037834A1 (en) |
| EP (1) | EP1274461A2 (en) |
| AU (1) | AU2001250212A1 (en) |
| CA (1) | CA2406593A1 (en) |
| WO (1) | WO2001080899A2 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6911429B2 (en) | 1999-04-01 | 2005-06-28 | Transition Therapeutics Inc. | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| US6864235B1 (en) | 1999-04-01 | 2005-03-08 | Eva A. Turley | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| US7318925B2 (en) | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
| DE60325906D1 (en) | 2003-08-08 | 2009-03-05 | Amgen Fremont Inc | ANTIBODIES TO PARATH-HORMONE (PTH) AND ITS USES |
| US7607592B1 (en) | 2004-11-08 | 2009-10-27 | Kim Sang B | Accessories for water and beverage bottles |
| JP5140579B2 (en) * | 2005-06-08 | 2013-02-06 | カンジェーン コーポレイション | Hyaluronic acid-binding peptide enhances defense against pathogens |
| WO2008140586A2 (en) * | 2006-11-21 | 2008-11-20 | The Regents Of The University Of California | Modulation of rhamm (cd168) for selective adipose tissue development |
| US20100062000A1 (en) * | 2006-11-21 | 2010-03-11 | The Regents Of The University Of California | Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations |
| USD590658S1 (en) | 2007-03-05 | 2009-04-21 | Richard Pola & Associates, Inc. | Cup with spritzing mechanism |
| AU2009270405B2 (en) | 2008-06-30 | 2014-06-05 | Esbatech, An Alcon Biomedical Research Unit Llc | Functionalized polypeptides |
| US8530189B2 (en) * | 2008-10-16 | 2013-09-10 | Kathleen Cogan Farinas | Sustained drug delivery system |
| EP2349339A4 (en) * | 2008-10-16 | 2015-01-07 | Kathleen Cogan Farinas | Sustained drug delivery system |
| US10494402B2 (en) | 2012-11-25 | 2019-12-03 | The Regents Of The University Of California | Peptides that stimulate subcutaneous adipogenesis |
| GB201400994D0 (en) * | 2014-01-21 | 2014-03-05 | Ucl Business Plc | Drug delivery system |
| US10844102B2 (en) | 2014-05-28 | 2020-11-24 | The Regents Of The University Of California | Peptides, compositions, and methods for stimulating subcutaneous adipogenesis |
| WO2016151478A1 (en) | 2015-03-20 | 2016-09-29 | London Health Sciences Centre Research Inc. | Stapled peptides and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06504912A (en) * | 1991-01-14 | 1994-06-09 | ニューヨーク・ユニバーシティ | Cytokine-inducing protein TSG-6, DNA encoding the TSG-6 protein, and use of the TSG-6 protein |
| GB9207949D0 (en) * | 1992-04-09 | 1992-05-27 | Univ Manitoba | Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility |
| KR970705401A (en) * | 1994-08-30 | 1997-10-09 | 사무엘 시몬 에스큘라이 | HYALURONIC ACID AND DERIVATIVES FOR MODULATION OF CELLULAR ACTIVITY FOR ADJUSTING CELL ACTIVITY |
| CA2205771C (en) * | 1997-05-22 | 2002-05-14 | Hyal Pharmaceutical Corporation | Improved delivery of disease modifiers |
| CA2237051A1 (en) * | 1997-12-19 | 1999-06-19 | Eva A. Turley | Enhanced affinity hyaluronan binding peptides |
-
2001
- 2001-04-20 AU AU2001250212A patent/AU2001250212A1/en not_active Abandoned
- 2001-04-20 US US10/257,377 patent/US20040037834A1/en not_active Abandoned
- 2001-04-20 CA CA002406593A patent/CA2406593A1/en not_active Abandoned
- 2001-04-20 EP EP01923439A patent/EP1274461A2/en not_active Withdrawn
- 2001-04-20 WO PCT/CA2001/000533 patent/WO2001080899A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1274461A2 (en) | 2003-01-15 |
| WO2001080899A2 (en) | 2001-11-01 |
| WO2001080899A3 (en) | 2002-09-06 |
| US20040037834A1 (en) | 2004-02-26 |
| CA2406593A1 (en) | 2001-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002233230A1 (en) | Erythropoietin conjugates | |
| AU2001262237A1 (en) | Reflector | |
| AU2003253048A1 (en) | Tubulysin conjugates | |
| AU2001254546A1 (en) | Aminopiperidines | |
| AU2001240026A1 (en) | Camptothecin conjugates | |
| AU2001220246A1 (en) | Neckphone | |
| AU2001239310A1 (en) | Decahydro-isoquinolines | |
| AU2001250212A1 (en) | Rhamm peptide conjugates | |
| AU2001271869A1 (en) | Conveyor bracket | |
| AU2001262689A1 (en) | Oligopeptides | |
| AU2001240791A1 (en) | Sequence | |
| AU2001289307A1 (en) | Chemically-modified myelopoietin conjugates | |
| AU5903000A (en) | Novel anti-thrombin peptide | |
| AU2001246864A1 (en) | Hypotensors | |
| AU2001226668A1 (en) | Crankshaft-starter-generator | |
| AU2002216749A1 (en) | Chemokine conjugates | |
| EP1201403A3 (en) | Electrofusible units | |
| AU2001282521A1 (en) | OCT preparations | |
| AU4308001A (en) | Transition metal-cyclopentadienyl-tropane conjugates | |
| AU2001257009A1 (en) | Enhanced hyperlink | |
| AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
| AU5090000A (en) | Barriers | |
| AU2001278975A1 (en) | Alpha-conotoxin peptides | |
| AU2002215145A1 (en) | Dual orientation connector | |
| AU2002240841A1 (en) | Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units |